Status:
UNKNOWN
Detection of Group A β-Hemolytic Streptococci in Oral Samples
Lead Sponsor:
Hero Scientific
Conditions:
Group A β-Hemolytic Streptococci
Eligibility:
All Genders
3+ years
Brief Summary
This prospective, sample collection study will assess different oral and/or nasal sample types collected from patients suspected of suffering from GABHS pharyngitis to conduct research and development...
Detailed Description
Study candidates are patients age 3 and older with complaints of sore throat and are suspected of suffering from GABHS pharyngitis. Patients who consent and are found eligible will be enrolled in the ...
Eligibility Criteria
Inclusion
- Patient, either male or female, is age 3 years or older;
- Patient is suspected of suffering from GABHS pharyngitis, and is prescribed a throat culture by conventional SOC;
- Patient or legal guardian is able to communicate with study personnel;
- Patient or legal guardian is able to understand oral and written information regarding the nature of the study and is willing to provide written informed consent.
Exclusion
- Patients presently on antibiotics prescribed by a physician for treatment or prevention of GAS infection or has taken antibiotics within the past 3 days ( unless patient only first started taking antibiotics within the past 24 hour)
- pregnancy
- Patients who took mouth rinse or taking oral treatment for mouth sores within 3 hours of study
Key Trial Info
Start Date :
November 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05223634
Start Date
November 18 2020
End Date
June 1 2022
Last Update
February 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leumit Healthcare services
Tel Aviv, Israel